Characterization of FCE 22101-resistant Enterobacteriaceae and the effect of FCE 22101 upon the activity of anti-pseudomonal beta-lactams for Pseudomonas aeruginosa
- PMID: 1960118
- DOI: 10.1093/jac/28.3.369
Characterization of FCE 22101-resistant Enterobacteriaceae and the effect of FCE 22101 upon the activity of anti-pseudomonal beta-lactams for Pseudomonas aeruginosa
Abstract
Twenty-five strains of Enterobacteriaceae (five each of Enterobacter cloacae, Citrobacter freundii, Serratia marcescens, Morganella morganii, and Providencia stuartii) were exposed to FCE 22101 in agar containing 3, 5, or 10 x the MIC. Any putative mutant with a greater than or equal to four-fold increase in the MIC was examined for beta-lactamase expression and outer membrane protein (OMP) profile. Mutant colonies were selected at a frequency of 10(-7)-10(-11) with decreased susceptibility to FCE 22101 and other beta-lactams, but after one subculture on antibiotic-free agar the mutants from 13 of the 25 strains reverted to wild-type. Only 19 stable mutants were selected from the other 12 wild-type strains, of which 15 lacked an OMP of similar molecular size to OmpF, and/or a low size OMP of approximately 18 kDa. None of the mutants had a significant alteration in expression of Richmond & Sykes class I beta-lactamase. In a separate section of the study in which 50 strains of Pseudomonas aeruginosa were examined, it was found that FCE 22101, at a concentration of 4 mg/L, induced beta-lactamase expression such that, after 24 h exposure, 24 of the 50 strains had a greater than or equal to four-fold rise in the MIC of several anti-pseudomonal beta-lactams.
Similar articles
-
beta-Lactamase expression and outer membrane protein changes in cefpirome-resistant and ceftazidime-resistant gram-negative bacteria.J Antimicrob Chemother. 1991 Aug;28(2):209-19. doi: 10.1093/jac/28.2.209. J Antimicrob Chemother. 1991. PMID: 1778852
-
A comparison of the mechanisms of decreased susceptibility of aztreonam-resistant and ceftazidime-resistant Enterobacteriaceae.J Antimicrob Chemother. 1990 Dec;26(6):749-62. doi: 10.1093/jac/26.6.749. J Antimicrob Chemother. 1990. PMID: 2081717
-
Selection and characterization of cefepime-resistant gram-negative bacteria.J Antimicrob Chemother. 1991 Nov;28(5):669-76. doi: 10.1093/jac/28.5.669. J Antimicrob Chemother. 1991. PMID: 1778870
-
Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?Int J Antimicrob Agents. 2012 Oct;40(4):297-305. doi: 10.1016/j.ijantimicag.2012.06.004. Epub 2012 Jul 21. Int J Antimicrob Agents. 2012. PMID: 22824371 Review.
-
Newer carbapenems for urinary tract infections.Int J Antimicrob Agents. 2004 Sep;24 Suppl 1:S35-8. doi: 10.1016/j.ijantimicag.2004.03.001. Int J Antimicrob Agents. 2004. PMID: 15364304 Review.
Cited by
-
Relative importances of outer membrane permeability and group 1 beta-lactamase as determinants of meropenem and imipenem activities against Enterobacter cloacae.Antimicrob Agents Chemother. 1995 Feb;39(2):350-5. doi: 10.1128/AAC.39.2.350. Antimicrob Agents Chemother. 1995. PMID: 7726496 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical